Rare Cancer News

  • Home
  • Rare Cancer News

Rare Cancer News We are dedicated to sharing the latest news, research, and rare cancer patient perspectives.

Two combination treatments using Blenrep have been approved in the European Union for adults with relapsed or refractory...
29/07/2025

Two combination treatments using Blenrep have been approved in the European Union for adults with relapsed or refractory multiple myeloma. https://buff.ly/ggXsElz

The European Commission has approved Aucatzyl (obecabtagene autoleucel) for B-cell precursor acute lymphoblastic leukemi...
28/07/2025

The European Commission has approved Aucatzyl (obecabtagene autoleucel) for B-cell precursor acute lymphoblastic leukemia (B-ALL). https://buff.ly/WyRJy5b

The experimental oral medication VS-7375 has been granted the FDA's fast track designation as a potential treatment for ...
25/07/2025

The experimental oral medication VS-7375 has been granted the FDA's fast track designation as a potential treatment for pancreatic cancer. https://buff.ly/lXRmKQZ

The repetitive routine of caregiving often leaves columnist Samuel Ike feeling like he's in "Groundhog Day." Here's how ...
24/07/2025

The repetitive routine of caregiving often leaves columnist Samuel Ike feeling like he's in "Groundhog Day." Here's how he gets unstuck. https://buff.ly/ZX8Emoo

Immune cells levels in blood may serve as biomarkers for glioma, potentially aiding diagnosis and predicting outcomes, p...
24/07/2025

Immune cells levels in blood may serve as biomarkers for glioma, potentially aiding diagnosis and predicting outcomes, per a study. https://buff.ly/poS5ulg

Uterine cancer cases and deaths, or its incidence and mortality rate, are projected to increase in the U.S., especially ...
23/07/2025

Uterine cancer cases and deaths, or its incidence and mortality rate, are projected to increase in the U.S., especially among Black women. https://buff.ly/LDZ9AnW

IGI and Abbvie have reached a $700 million deal to develop ISB 2001, a multiple myeloma treatment that uses antibody eng...
22/07/2025

IGI and Abbvie have reached a $700 million deal to develop ISB 2001, a multiple myeloma treatment that uses antibody engineering technology. https://buff.ly/fS6btGN

The FDA has granted the immune-modulating therapy ICT01 orphan drug designation as a potential treatment for acute myelo...
21/07/2025

The FDA has granted the immune-modulating therapy ICT01 orphan drug designation as a potential treatment for acute myeloid leukemia. https://buff.ly/TilSdUI

Quemliclustat has been granted the U.S. FDA's orphan drug status for pancreatic cancer. A Phase 3 trial of quemliclustat...
18/07/2025

Quemliclustat has been granted the U.S. FDA's orphan drug status for pancreatic cancer. A Phase 3 trial of quemliclustat is now recruiting. https://buff.ly/3PMK9yZ

The FDA has granted the CAR T-cell therapy MB-101 orphan drug designation as a cancer treatment for certain malignant gl...
18/07/2025

The FDA has granted the CAR T-cell therapy MB-101 orphan drug designation as a cancer treatment for certain malignant gliomas. https://buff.ly/YfvEsZR

Caregiver anger can be uncomfortable to talk about, but we must acknowledge it, writes columnist Samuel Ike, who offers ...
17/07/2025

Caregiver anger can be uncomfortable to talk about, but we must acknowledge it, writes columnist Samuel Ike, who offers helpful tips. https://buff.ly/m52bFQ7

Today marks Glioblastoma Awareness Day, and we’re joining with our partners, advocates, and every patient and family fac...
16/07/2025

Today marks Glioblastoma Awareness Day, and we’re joining with our partners, advocates, and every patient and family facing a brain cancer diagnosis.

Glioblastoma, like so many rare cancers, urgently needs better treatments and increased research funding. TargetCancer Foundation is working to make sure this happens.

By raising our voices together, we hope to drive attention, resources, and real progress for this community. Visit https://targetcancer.org/ to learn more.

Address


Website

Alerts

Be the first to know and let us send you an email when Rare Cancer News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Address
  • Alerts
  • Claim ownership or report listing

  • Want your practice to be the top-listed Clinic?

Share